Glycerol phenylbutyrate and Insulin lispro Subcutaneous
Determining the interaction of Glycerol phenylbutyrate and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glycerol phenylbutyrate
Brand name: Ravicti
Synonyms: n.a.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glycerol phenylbutyrate-Insulin NPH
- Glycerol phenylbutyrate-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Glycerol phenylbutyrate-Insulin NPH (Vials)
- Glycerol phenylbutyrate-Insulin NPH and Insulin Regular
- Glycerol phenylbutyrate-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Glycerol phenylbutyrate-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-GlycoLax
- Insulin lispro Subcutaneous-Glycophos
- Insulin lispro Subcutaneous-Glycophos Injection
- Insulin lispro Subcutaneous-Glycopyrrolate
- Insulin lispro Subcutaneous-Glycopyrrolate (Oral Inhalation)
- Insulin lispro Subcutaneous-Glycopyrrolate (Systemic)